Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

References for PMC Articles for PubMed (Select 20451869)

1.

Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease.

McEvoy LK, Edland SD, Holland D, Hagler DJ Jr, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM; Alzheimerʼs Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):269-77. doi: 10.1097/WAD.0b013e3181d1b814.

2.

Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans.

Hua X, Hibar DP, Lee S, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1463-80. doi: 10.1016/j.neurobiolaging.2010.04.033.

3.

Boosting power for clinical trials using classifiers based on multiple biomarkers.

Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1429-42. doi: 10.1016/j.neurobiolaging.2010.04.022. Epub 2010 Jun 11.

4.

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.

Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Jun;51(2):654-64. doi: 10.1016/j.neuroimage.2010.02.064. Epub 2010 Mar 2.

5.

Voxelwise genome-wide association study (vGWAS).

Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson P; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Nov 15;53(3):1160-74. doi: 10.1016/j.neuroimage.2010.02.032. Epub 2010 Feb 17.

6.

CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.

Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2010 Feb 10;30(6):2088-101. doi: 10.1523/JNEUROSCI.3785-09.2010.

7.

Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.

Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 May 15;51(1):63-75. doi: 10.1016/j.neuroimage.2010.01.104. Epub 2010 Feb 6.

8.

Sex-dependent association of common variants of microcephaly genes with brain structure.

Rimol LM, Agartz I, Djurovic S, Brown AA, Roddey JC, Kähler AK, Mattingsdal M, Athanasiu L, Joyner AH, Schork NJ, Halgren E, Sundet K, Melle I, Dale AM, Andreassen OA; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):384-8. doi: 10.1073/pnas.0908454107. Epub 2009 Dec 22.

9.

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, Jennings RG, Karow D, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2010 Feb;31(2):347-54. doi: 10.3174/ajnr.A1809. Epub 2010 Jan 14.

10.

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Blennow K, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Cereb Cortex. 2010 Sep;20(9):2069-79. doi: 10.1093/cercor/bhp279. Epub 2010 Jan 4.

11.

Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.

Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR Jr, Weiner MW, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Apr 1;50(2):516-23. doi: 10.1016/j.neuroimage.2009.12.059. Epub 2009 Dec 23.

12.

Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.

Evans MC, Barnes J, Nielsen C, Kim LG, Clegg SL, Blair M, Leung KK, Douiri A, Boyes RG, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Eur Radiol. 2010 Mar;20(3):674-82. doi: 10.1007/s00330-009-1581-5. Epub 2009 Sep 16.

PMID:
19760240
13.

A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations.

Joyner AH, J CR, Bloss CS, Bakken TE, Rimol LM, Melle I, Agartz I, Djurovic S, Topol EJ, Schork NJ, Andreassen OA, Dale AM.

Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15483-8. doi: 10.1073/pnas.0901866106. Epub 2009 Aug 26.

14.

Regional rates of neocortical atrophy from normal aging to early Alzheimer disease.

McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ Jr, Holland D, Koyama A, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Aug 11;73(6):457-65. doi: 10.1212/WNL.0b013e3181b16431.

15.

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb.

16.

MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):287-93. doi: 10.1212/WNL.0b013e3181af79e5.

17.

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.

Hua X, Lee S, Yanovsky I, Leow AD, Chou YY, Ho AJ, Gutman B, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 Dec;48(4):668-81. doi: 10.1016/j.neuroimage.2009.07.011. Epub 2009 Jul 14.

18.

Measurement of MRI scanner performance with the ADNI phantom.

Gunter JL, Bernstein MA, Borowski BJ, Ward CP, Britson PJ, Felmlee JP, Schuff N, Weiner M, Jack CR.

Med Phys. 2009 Jun;36(6):2193-205.

19.

Comparison of phantom and registration scaling corrections using the ADNI cohort.

Clarkson MJ, Ourselin S, Nielsen C, Leung KK, Barnes J, Whitwell JL, Gunter JL, Hill DL, Weiner MW, Jack CR Jr, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 Oct 1;47(4):1506-13. doi: 10.1016/j.neuroimage.2009.05.045. Epub 2009 May 27.

20.

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Apr;132(Pt 4):1067-77. doi: 10.1093/brain/awp007. Epub 2009 Feb 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk